Published in Women's Health Weekly, August 3rd, 2006
"Because antiangiogenic therapies inhibit the growth of new tumor-associated blood vessels, as well as prime newly formed vasculature, they would be expected to reduce the supply of oxygen and thus increase tumor hypoxia. However, it is not clear if antiangiogenic treatments lead only to consistent and sustained increases in hypoxia, or transient decreases in tumor hypoxia along with periods of increased hypoxia," researchers in Canada report.
"We undertook a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly